GoodRx Inc. (GDRX)
GoodRx Statistics
Share Statistics
GoodRx has 383.61M shares outstanding. The number of shares has increased by -3.51% in one year.
| Shares Outstanding | 383.61M |
| Shares Change (YoY) | -3.51% |
| Shares Change (QoQ) | 0.45% |
| Owned by Institutions (%) | 35.81% |
| Shares Floating | 319.41M |
| Failed to Deliver (FTD) Shares | 1 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 7.58M, so 1.99% of the outstanding shares have been sold short.
| Short Interest | 7.58M |
| Short % of Shares Out | 1.99% |
| Short % of Float | 2.39% |
| Short Ratio (days to cover) | 5.66 |
Valuation Ratios
The PE ratio is 109.44 and the forward PE ratio is 12.26. GoodRx's PEG ratio is -0.17.
| PE Ratio | 109.44 |
| Forward PE | 12.26 |
| PS Ratio | 2.26 |
| Forward PS | 1.5 |
| PB Ratio | 2.48 |
| P/FCF Ratio | 11004.15 |
| PEG Ratio | -0.17 |
Enterprise Valuation
GoodRx Inc. has an Enterprise Value (EV) of 2.79B.
| EV / Earnings | 170.1 |
| EV / Sales | 3.52 |
| EV / EBITDA | 18.11 |
| EV / EBIT | 42.34 |
| EV / FCF | 17103.59 |
Financial Position
The company has a current ratio of 5.32, with a Debt / Equity ratio of 0.08.
| Current Ratio | 5.32 |
| Quick Ratio | 5.32 |
| Debt / Equity | 0.08 |
| Total Debt / Capitalization | 7.25 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 1.24 |
Financial Efficiency
Return on equity (ROE) is 0.02% and return on capital (ROIC) is 4.39%.
| Return on Equity (ROE) | 0.02% |
| Return on Assets (ROA) | 0.01% |
| Return on Capital (ROIC) | 4.39% |
| Revenue Per Employee | $1,073,609.76 |
| Profits Per Employee | $22,208.67 |
| Employee Count | 738 |
| Asset Turnover | 0.57 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 15.07M |
| Effective Tax Rate | 0.48 |
Stock Price Statistics
The stock price has increased by -36.2% in the last 52 weeks. The beta is 1.26, so GoodRx's price volatility has been higher than the market average.
| Beta | 1.26 |
| 52-Week Price Change | -36.2% |
| 50-Day Moving Average | 4.75 |
| 200-Day Moving Average | 6.21 |
| Relative Strength Index (RSI) | 44.23 |
| Average Volume (20 Days) | 1.47M |
Income Statement
In the last 12 months, GoodRx had revenue of 792.32M and earned 16.39M in profits. Earnings per share was 0.12.
| Revenue | 792.32M |
| Gross Profit | 744.11M |
| Operating Income | 65.85M |
| Net Income | 16.39M |
| EBITDA | 153.92M |
| EBIT | 65.85M |
| Earnings Per Share (EPS) | 0.12 |
Balance Sheet
The company has 448.35M in cash and 56.68M in debt, giving a net cash position of 391.67M.
| Cash & Cash Equivalents | 448.35M |
| Total Debt | 56.68M |
| Net Cash | 391.67M |
| Retained Earnings | -1.44B |
| Total Assets | 1.39B |
| Working Capital | 535.35M |
Cash Flow
In the last 12 months, operating cash flow was 163K and capital expenditures 0, giving a free cash flow of 163K.
| Operating Cash Flow | 163K |
| Capital Expenditures | 0 |
| Free Cash Flow | 163K |
| FCF Per Share | 0 |
Margins
Gross margin is 93.91%, with operating and profit margins of 8.31% and 2.07%.
| Gross Margin | 93.91% |
| Operating Margin | 8.31% |
| Pretax Margin | 3.97% |
| Profit Margin | 2.07% |
| EBITDA Margin | 19.43% |
| EBIT Margin | 8.31% |
| FCF Margin | 0.02% |
Dividends & Yields
GDRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 2.65% |
| FCF Yield | 0.01% |
Analyst Forecast
The average price target for GDRX is $8, which is 76.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $8 |
| Price Target Difference | 76.6% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
Scores
| Altman Z-Score | 1.36 |
| Piotroski F-Score | 8 |